W. T. V. Germeraad
AuthID: R-00J-X5M
1
TITLE: Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy Full Text
AUTHORS: Gong, Y; Wolterink, RGJK; Wang, JX; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: JOURNAL OF HEMATOLOGY & ONCOLOGY, VOLUME: 14, ISSUE: 1
AUTHORS: Gong, Y; Wolterink, RGJK; Wang, JX; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: JOURNAL OF HEMATOLOGY & ONCOLOGY, VOLUME: 14, ISSUE: 1
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity Full Text
AUTHORS: Gong, Y; Wolterink, RGJK; Gulaia, V; Cloosen, S; Ehlers, FAI; Wieten, L; Graus, YF; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 11
AUTHORS: Gong, Y; Wolterink, RGJK; Gulaia, V; Cloosen, S; Ehlers, FAI; Wieten, L; Graus, YF; Bos, GMJ; Germeraad, WTV;
PUBLISHED: 2021, SOURCE: CANCERS, VOLUME: 13, ISSUE: 11
INDEXED IN: Scopus WOS
Scopus WOS